Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)

Clinical trial NCT05338099 · COMPLETED

Trial details

NCT number: NCT05338099
Sponsor: ENCell
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2022-01-18
Primary completion: 2022-12-28
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.